Table 1. Relationship of level of drug adherence with patient gender and duration of LT4 prescription.
DA, drug adherence; LT4, levothyroxine
| Level of drug adherence | Total sample (n=289) | Gender | Duration of LT4 prescription | ||||
| Male (n=88) | Female (n=201) | P value | 1-5 years (n=149) | > 5 years (n=140) | P value | ||
| High DA | 93 (32.2%) | 43 (48.8%) | 50 (24.8%) | 0.0002 | 28 (18.7%) | 65 (46.4%) | <0.00001 |
| Medium DA | 117 (40.5%) | 29 (32.9%) | 88 (43.7%) | 87 (58.3%) | 30 (21.4%) | ||
| Low DA | 79 (27.3%) | 16 (18.2%) | 63 (31.3%) | 34 (22.8%) | 45 (32.1%) | ||